Indantadol
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Indantadol
- DrugBank Accession Number
- DB12664
- Background
Indantadol has been used in trials studying the treatment of Cough and Diabetic Peripheral Neuropathic Pain.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 190.246
Monoisotopic: 190.110613079 - Chemical Formula
- C11H14N2O
- Synonyms
- Indantadol
- External IDs
- V3381
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Indantadol hydrochloride YHA48V735B 202914-18-9 JPNNIRXUJSPGRM-UHFFFAOYSA-N
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids.
- Kingdom
- Organic compounds
- Super Class
- Organic acids and derivatives
- Class
- Carboxylic acids and derivatives
- Sub Class
- Amino acids, peptides, and analogues
- Direct Parent
- Alpha amino acid amides
- Alternative Parents
- Indanes / Aralkylamines / Primary carboxylic acid amides / Dialkylamines / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
- Substituents
- Alpha-amino acid amide / Amine / Aralkylamine / Aromatic homopolycyclic compound / Benzenoid / Carbonyl group / Carboxamide group / Hydrocarbon derivative / Indane / Organic nitrogen compound
- Molecular Framework
- Aromatic homopolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Z3867B9SQP
- CAS number
- 202844-10-8
- InChI Key
- MNLULKBKWKTZPE-UHFFFAOYSA-N
- InChI
- InChI=1S/C11H14N2O/c12-11(14)7-13-10-5-8-3-1-2-4-9(8)6-10/h1-4,10,13H,5-7H2,(H2,12,14)
- IUPAC Name
- 2-[(2,3-dihydro-1H-inden-2-yl)amino]acetamide
- SMILES
- NC(=O)CNC1CC2=CC=CC=C2C1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 10192617
- PubChem Substance
- 347828868
- ChemSpider
- 8368117
- ZINC
- ZINC000000009005
- Wikipedia
- Indantadol
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Completed Treatment Diabetic Neuropathies / Pain 1 2 Completed Treatment Diabetic Peripheral Neuropathic Pain (DPN) 1 2 Terminated Treatment Cough 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.485 mg/mL ALOGPS logP 0.79 ALOGPS logP 0.59 Chemaxon logS -2.6 ALOGPS pKa (Strongest Acidic) 16.4 Chemaxon pKa (Strongest Basic) 8.61 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 55.12 Å2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 54.95 m3·mol-1 Chemaxon Polarizability 21.07 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-015d-4900000000-fdd5d4056a935c6320c2 Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-00kf-1900000000-c1007b3f1ec6de14b5d2 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-00di-9100000000-d0e8080d75c5c73c702c Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0a4i-9100000000-86796c5f57564a27cf5f Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-00kg-4900000000-58c76b38b1906c770105 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-052f-9600000000-ba4fe560873d4321f254 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-014i-2900000000-1e9b4075b6eadba13efb Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 138.76302 predictedDeepCCS 1.0 (2019) [M+H]+ 141.31384 predictedDeepCCS 1.0 (2019) [M+Na]+ 149.88918 predictedDeepCCS 1.0 (2019)
Drug created at October 20, 2016 23:32 / Updated at February 21, 2021 18:53